Dimensional Fund Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08B Sell
7,722,929
-1,123,384
-13% -$157M 0.22% 52
2025
Q4
$1.09B Sell
8,846,313
-711,455
-7% -$86.5M 0.23% 50
2025
Q3
$1.06B Sell
9,557,768
-566,769
-6% -$64.4M 0.23% 48
2025
Q2
$1.12B Sell
10,124,537
-375,920
-4% -$40M 0.26% 42
2025
Q1
$1.18B Sell
10,500,457
-1,107,145
-10% -$114M 0.29% 39
2024
Q4
$1.07B Sell
11,607,602
-61,773
-0.5% -$5.56M 0.26% 44
2024
Q3
$978M Buy
11,669,375
+1,256,962
+12% +$95.9M 0.24% 46
2024
Q2
$714M Buy
10,412,413
+268,208
+3% +$17.9M 0.19% 68
2024
Q1
$743M Buy
10,144,205
+361,010
+4% +$27.8M 0.2% 65
2023
Q4
$793M Buy
9,783,195
+287,080
+3% +$22.3M 0.23% 51
2023
Q3
$712M Buy
9,496,115
+414,378
+5% +$31.9M 0.23% 51
2023
Q2
$700M Buy
9,081,737
+62,444
+0.7% +$4.98M 0.22% 52
2023
Q1
$748M Buy
9,019,293
+46,564
+0.5% +$3.86M 0.25% 48
2022
Q4
$770K Sell
8,972,729
-116,113
-1% -$9.2M 0.23% 51
2022
Q3
$561M Buy
9,088,842
+280,256
+3% +$17.7M 0.22% 56
2022
Q2
$544M Buy
8,808,586
+286,885
+3% +$17.8M 0.2% 68
2022
Q1
$507M Buy
8,521,701
+1,231,734
+17% +$78.7M 0.16% 96
2021
Q4
$529M Buy
7,289,967
+541,329
+8% +$37.3M 0.16% 88
2021
Q3
$471M Buy
6,748,638
+894,368
+15% +$62.8M 0.15% 92
2021
Q2
$403M Buy
5,854,270
+1,435,775
+32% +$95.9M 0.13% 112
2021
Q1
$286M Sell
4,418,495
-671,039
-13% -$43.3M 0.09% 190
2020
Q4
$296M Sell
5,089,534
-9,954
-0.2% -$601K 0.11% 138
2020
Q3
$322M Sell
5,099,488
-155,762
-3% -$10.8M 0.14% 101
2020
Q2
$404M Buy
5,255,250
+69,009
+1% +$5.29M 0.18% 70
2020
Q1
$388M Sell
5,186,241
-17,038
-0.3% -$1.18M 0.2% 61
2019
Q4
$338M Buy
5,203,279
+110,388
+2% +$7.19M 0.12% 106
2019
Q3
$323M Sell
5,092,891
-5,353
-0.1% -$350K 0.13% 102
2019
Q2
$344M Buy
5,098,244
+16
+0% +$1.05K 0.13% 91
2019
Q1
$331M Sell
5,098,228
-30,969
-0.6% -$2.06M 0.13% 94
2018
Q4
$321M Buy
5,129,197
+51,905
+1% +$3.63M 0.15% 84
2018
Q3
$392M Sell
5,077,292
-165,271
-3% -$12.5M 0.15% 81
2018
Q2
$371M Buy
5,242,563
+348,111
+7% +$24.6M 0.15% 79
2018
Q1
$369M Buy
4,894,452
+241,083
+5% +$19.2M 0.15% 80
2017
Q4
$333M Buy
4,653,369
+613,521
+15% +$46.6M 0.14% 93
2017
Q3
$327M Buy
4,039,848
+412,372
+11% +$31.5M 0.14% 92
2017
Q2
$257M Buy
3,627,476
+524,817
+17% +$34.9M 0.12% 124
2017
Q1
$211M Buy
3,102,659
+12,584
+0.4% +$885K 0.1% 168
2016
Q4
$221M Buy
3,090,075
+31,819
+1% +$2.37M 0.11% 140
2016
Q3
$242M Buy
3,058,256
+23,640
+0.8% +$1.92M 0.13% 107
2016
Q2
$253M Buy
3,034,616
+33,533
+1% +$2.98M 0.15% 92
2016
Q1
$276M Buy
3,001,083
+87,481
+3% +$7.89M 0.17% 80
2015
Q4
$295M Buy
2,913,602
+228,120
+8% +$23.7M 0.18% 66
2015
Q3
$264M Buy
2,685,482
+115,947
+5% +$12.9M 0.17% 74
2015
Q2
$301M Buy
2,569,535
+159,174
+7% +$17.4M 0.18% 63
2015
Q1
$237M Buy
2,410,361
+69,810
+3% +$7.09M 0.15% 90
2014
Q4
$221M Buy
2,340,551
+148,161
+7% +$15.3M 0.14% 96
2014
Q3
$233M Buy
2,192,390
+220,316
+11% +$21.6M 0.17% 86
2014
Q2
$164M Buy
1,972,074
+111,951
+6% +$8.71M 0.11% 140
2014
Q1
$132M Buy
1,860,123
+359,488
+24% +$28.2M 0.1% 185
2013
Q4
$113M Buy
1,500,635
+39,911
+3% +$2.78M 0.09% 210
2013
Q3
$91.8M Buy
1,460,724
+32,891
+2% +$1.97M 0.08% 261
2013
Q2
$73.1M Buy
+1,427,833
New +$74.4M 0.07% 308

Other funds holding GILD

Dimensional Fund Advisors's GILD Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Gilead Sciences (GILD) stake by 13% in Q1 2026, selling an estimated $157M and leaving 7,722,929 shares worth $1.08B. The position accounts for 0.22% of the portfolio, ranked #52.

Dimensional Fund Advisors first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.18B in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Dimensional Fund Advisors held 7,722,929 shares of Gilead Sciences worth $1.08B as of Q1 2026.
  • Dimensional Fund Advisors sold 1,123,384 Gilead Sciences shares in Q1 2026, an estimated $157M.
  • Gilead Sciences made up 0.22% of Dimensional Fund Advisors's portfolio in Q1 2026, its #52 holding.
  • Dimensional Fund Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Dimensional Fund Advisors's Gilead Sciences position peaked at $1.18B in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.